AUS
NZ
UK
CA
USA
IND
On July 23, 2026, LDIC Inc. (TSX: MDS.UN) revealed plans to terminate the Healthcare Special Opportunities Fund in Q3 2026, pending approval from unitholders and regulators. The fund’s private investments will be moved to a newly formed limited partnership, Healthcare Special Opportunities Sidecar LP, with limited partnership interests distributed proportionally to unitholders. Subsequently, the fund’s Class A units will be delisted from the Toronto Stock Exchange, remaining assets liquidated, and all units redeemed for cash.
Key Highlights
- LDIC Inc. (TSX: MDS.UN) acts as manager and trustee overseeing the proposed fund termination
- Termination targeted for Q3 2026, contingent on unitholder and regulatory consent
- Special unitholder meeting set for September 4, 2026; record date August 5, 2026; Class A units expected to be delisted from TSX around September 21, 2026
- Private investments to be transferred to Healthcare Special Opportunities Sidecar LP, with limited partnership interests allocated to unitholders on a pro rata basis
Strategic Assessment Drives Fund Termination Decision
Following a comprehensive review of the Healthcare Special Opportunities Fund’s operational and financial framework, LDIC Inc. concluded that terminating the fund is the optimal course. Factors influencing this decision included the fund’s asset size, management expense ratio, portfolio mix, and notably, the liquidity challenges posed by its illiquid private investment holdings.
Management determined that exploring strategic alternatives to enhance liquidity would better serve unitholders than maintaining the existing fund structure. The proposed termination combined with the sidecar LP structure represents the preferred solution emerging from this evaluation.
Creation of Sidecar LP and Asset Transfer Details
LDIC Inc. will establish Healthcare Special Opportunities Sidecar LP as a limited partnership vehicle to hold all private investments currently in the fund. In exchange, the fund will receive limited partnership interests that will be distributed to unitholders proportionally based on their current unit holdings.
This sidecar structure isolates illiquid private assets within a dedicated entity, enabling the fund itself to be wound down and its liquid assets distributed. This arrangement allows unitholders to retain exposure to private investments through direct limited partnership interests, potentially offering enhanced transparency and flexibility compared to the fund format.
Delisting and Fund Liquidation Process
Subject to all necessary approvals, LDIC Inc. plans to voluntarily delist the Healthcare Special Opportunities Fund’s Class A units (TSX: MDS.UN) from the Toronto Stock Exchange effective at market close on or about September 21, 2026. Until then, units will continue trading normally, allowing unitholders to buy or sell prior to termination.
After transferring private investments to the sidecar LP and delisting, the Manager will liquidate remaining fund assets, settle liabilities, redeem all units for cash, and formally terminate the fund in compliance with its Declaration of Trust and applicable securities laws across Canadian jurisdictions where LDIC is registered.
Unitholder Meeting and Voting Schedule
A special meeting of Healthcare Special Opportunities Fund unitholders is scheduled for September 4, 2026, to vote on the proposed transaction and related matters. The record date to determine voting eligibility is August 5, 2026. This timeline provides unitholders ample opportunity to review materials, seek advice, and prepare for the vote.
While the announcement does not disclose the current number of unitholders or units outstanding, LDIC encourages unitholders to consult financial and tax advisors to assess the transaction’s impact on their investment and tax situations.
Independent Review Committee’s Conflict of Interest Evaluation
The fund’s Independent Review Committee (IRC) conducted a formal conflict of interest assessment related to the proposed transaction. The IRC concluded that, if implemented as proposed, the transaction would be fair and reasonable to the fund and its unitholders. This independent evaluation assures that unitholder interests are protected despite potential conflicts.
However, IRC approval does not guarantee regulatory or unitholder consent, both of which remain prerequisites for completion. The IRC’s findings affirm that the proposed process treats all unitholders equitably.
Regulatory Compliance and Oversight
The fund’s termination is contingent on approvals from unitholders and regulatory bodies. LDIC Inc. holds Portfolio Manager registrations in Alberta, British Columbia, Manitoba, Ontario, Québec, and Saskatchewan, and is registered as an Investment Fund Manager in Ontario, Québec, and Newfoundland and Labrador. These registrations define the regulatory framework governing the fund’s operations and its termination.
The transaction must comply with securities laws in all jurisdictions where the fund is offered or unitholders reside. The TSX delisting requires formal exchange approval, and the liquidation and unit redemption must adhere to the fund’s Declaration of Trust and applicable provincial and federal securities regulations.
Tax and Financial Advisory Recommendations for Unitholders
LDIC Inc. strongly advises all unitholders to consult their financial and tax advisors to understand the tax consequences and financial implications of the proposed termination, asset transfer to the sidecar LP, receipt of limited partnership interests, and unit redemption. Tax outcomes will vary based on individual circumstances, cost basis, and residence.
Unitholders should carefully evaluate their investment goals and tax positions before the September 4, 2026 meeting to determine if the restructuring aligns with their objectives.
About LDIC Inc. and Fund Management
LDIC Inc. serves as trustee, manager, and investment advisor for the Healthcare Special Opportunities Fund. The firm manages portfolios for mid- to high-net-worth clients, corporations, and foundations, overseeing a range of actively managed proprietary funds. LDIC’s regulatory registrations enable it to serve clients across multiple Canadian provinces and manage both individual and collective investment vehicles.
LDIC emphasizes a disciplined, performance-driven investment approach with a collaborative team structure designed to adapt to changing market conditions. The decision to terminate the fund reflects management’s view that the current fund structure no longer optimally meets unitholders’ needs given the portfolio’s asset composition and liquidity profile.
Next Steps and Ongoing Communications
LDIC Inc. plans to issue a further press release around the termination date confirming final transaction details and completion. Until delisting and termination are finalized, the fund’s Class A units will continue trading on the TSX under ticker MDS.UN, with normal operations maintained. Unitholders will receive official meeting materials and transaction documentation ahead of the September 4, 2026 meeting as required by securities regulations and fund governance.
The immediate impact on share price remains unclear from public information. Unitholders should monitor LDIC’s official communications and thoroughly review all materials to understand transaction mechanics, timing, and effects on their holdings. Professional financial and tax advice is strongly recommended prior to voting.
